Jacqueline Forman

Jacqueline Forman

Auto-generated profile, based on publicly available information

Jacqueline Forman

Center for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia , Room 220, 1033 Davie St. Vancouver BC, V6E 1M7 , Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in EP Europace
Verified
Journal Article
Open access
PDF file
MDMarc W Deyell
Marc W Deyell
KHKurt Hoskin
Kurt Hoskin
JFJacqueline Forman
Jacqueline Forman
ZLZachary Laksman
Zachary Laksman
NHNathaniel M Hawkins
Nathaniel M Hawkins
JAJason G Andrade
Jason G Andrade
Same-day discharge is increasingly common after catheter ablation for atrial fibrillation (AF). However, the impact of same-day discharge on healthcare utilization after ablation and whether this differs by ablation modality remains uncertain. We examined the safety, efficacy, and subsequent healthcare utilization of a same-day discharge protocol for AF ablation, including radiofrequency (RF) and cryoballoon ablation, in a contemporary cohort. All consecutive patients for whom full healthcare utilization data were available at two centres and who underwent AF ablation from 2018 to 2019 were included. Same-day discharge was the default strategy for all patients. The efficacy and safety outcomes were proportions of same-day discharge and readmission/emergency room (ER) visits, and post-discharge complications, respectively. Of the 421 patients who underwent AF ablation (mean 63.3 ± 10.2 years, 33% female), 90.5% (381/421) achieved same-day discharge with no difference between RF and cryoballoon ablation (89.8 vs. 95.1%, adjusted P = 0.327). Readmission ≤30 days occurred in 4.8%, with ER visits ≤30 days seen in 26.1% with no difference between ablation modalities (P = 0.634). Patients admitted overnight were more likely to present to the ER (40.0 vs. 24.7% with same-day discharge, P = 0.036). The overall post-discharge complication rate was low at 4/421 (1.0%), with no difference between ablation modality (P = 0.324) and admission/same-day discharge (P = 0.485). Same-day discharge can be achieved in a majority of patients undergoing RF or cryoballoon ablation for AF. Healthcare utilization, particularly ER visits, remains high after AF ablation, regardless of ablation modality or same-day discharge.

27 January 2023 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
BDBrianna Davies
Brianna Davies
JFJacqueline Forman
Jacqueline Forman
CMCheryl McIlroy
Cheryl McIlroy
HJHeather Joe
Heather Joe
SSSina Safabakhsh
Sina Safabakhsh
ZLZachary Laksman
Zachary Laksman
Aims: Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. Insertable cardiac monitors (ICMs) are increasingly used in this population to provide closer monitoring, with the potential for notification systems. However, little is known regarding the psychological impact this information may have on patients. The Abbott Confirm Rx™ ICM has the capability of connecting to the patient’s smartphone to enable active participation in their care, as well as two-way communication between the patient and their care providers. This study aimed to explore individuals’ experiences of having a smartphone-enabled ICM to monitor for arrhythmias in HCM. Methods and results: Semi-structured interviews were conducted with 10 participants. Utilizing a grounded theory approach, the interview guide was modified based on emerging themes throughout the study. Reflexive thematic analysis was applied to categorize interview data into codes and overacting themes, with each interview independently coded by two study members. Analysis revealed three key themes: (i) psychological impact, (ii) educational needs, and (iii) technology expectations. Participants reported that receiving feedback from ICM transmissions resulted in improved symptom clarity, providing reassurance, and aiding implantable cardioverter defibrillator decision-making. Some participants reported uncertainty regarding when to send manual transmissions. Lastly, participants reported the app interface did not meet expectations with regard to the amount of data available for patients. Conclusion: Overall, utilizing a smartphone app to facilitate two-way communication of ICM transmissions was well accepted. Future directions include addressing gaps in educational needs and improvements in the patient interface with increased access to data.